Transdermal Drug Delivery Systems Market 2021 Size, Share, Growth, Trends, Scope, and Industry Forecast Till 2023 | Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG

According to a new report published by Allied Market Research, titled, Global Transdermal Drug Delivery Systems Market was valued at $32,516 million in 2016, and is estimated to reach $61,689 million by 2023, growing at a CAGR of 9.5% during the study period.

The passive system segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of chronic disorders, such as hypertension. The active system segment is expected to register highest CAGR of 12.8% during the forecast period.

Download Sample PDF of Report @

https://www.alliedmarketresearch.com/request-sample/485

Transdermal drug delivery systems are used to deliver drug through intact skin at a controlled rate into the systemic circulation. Increase in geriatric population and rise in number of patients suffering from chronic disorders, such as hypertension, diabetes, and angina, are expected to drive the market growth. Moreover, surge in adoption of new delivery system technologies, such as ultrasound, boosts the market growth. However, disadvantages of these delivery systems, such as irritation at the site of application and edema, are expected to impede the market growth.

Key Findings of the Transdermal Drug Delivery Systems Market:

Reservoir system segment is projected to grow at a CAGR of 7.3% during the forecast period.

Matrix system contributed for nearly two-third share of the global passive transdermal drug delivery systems market, in 2016.

Structure-based drug delivery system segment is expected to register the highest CAGR of 13.3% during the analysis period.

Cardiovascular disorders segment is expected to grow at the highest CAGR of 10.8% during the forecast period.

France and Germany collectively contributed for more than one-third share of the European transdermal drug delivery systems market in 2016.

Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific transdermal drug delivery systems market in 2016.

Inquiry for Buying Report @

https://www.alliedmarketresearch.com/purchase-enquiry/485

Asia-Pacific is projected to register the highest CAGR of 10.1% during the forecast period, owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective technologies in these nations offer a lucrative opportunity for the market growth.

The key companies operating in the market include Novartis AG, Johnson & Johnson, Mylan N.V., Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Acrux Limited, Echo Therapeutics, Inc., and Endo Pharmaceuticals Inc.

Transdermal Drug Delivery Systems Market Key Segments:

By Application:

Analgesics
Hormone Replacement Therapy
Cardiovascular Disorders
Motion Sickness
Smoking Cessation
Others

Read More:

https://www.alliedmarketresearch.com/transdermal-drug-delivery-systems-market

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, and researchers and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.

This release was published on openPR.